Adiponectin and basic fibroblast growth factor predict coronary collateral development in chronic total occlusion

doi:10.4330/wjc.124634

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 9

This Article

(0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Cardiol. Sep 26, 2026; 18(9): 124634
Published online Sep 26, 2026. doi: 10.4330/wjc.124634

Full Size Figure Download Figure

Figure 3 Receiver operating characteristic analysis of adiponectin and basic fibroblast growth factor for predicting good coronary collateral development. AUC: Area under the curve; CI: Confidence interval.

Citation: Gani A, Diah M, Riswan M, Muwardi, Heriadi. Adiponectin and basic fibroblast growth factor predict coronary collateral development in chronic total occlusion. World J Cardiol 2026; 18(9): 124634
URL: https://www.wjgnet.com/1949-8462/full/v18/i9/124634.htm
DOI: https://dx.doi.org/10.4330/wjc.124634

Gani A, Diah M, Riswan M, Muwardi, Heriadi. Adiponectin and basic fibroblast growth factor predict coronary collateral development in chronic total occlusion. World J Cardiol 2026; 18(9): 124634 [DOI: 10.4330/wjc.124634]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.